Education
About Us
Working with TipRanks
Follow Us
Vicarious Surgical Inc. (RBOT)
:RBOT
RBOT Stock Chart & Stats
$6.08
-$0.68(-4.53%)
At close: 4:00 PM EST
$6.08
-$0.68(-4.53%)
Day’s Range― - ―
52-Week Range$5.00 - $19.00
Previous CloseN/A
Volume30.88K
Average Volume (3M)88.27K
Market Cap
$39.81M
Enterprise Value$33.77M
Total Cash (Recent Filing)$23.96M
Total Debt (Recent Filing)$13.20M
Price to Earnings (P/E)―
Beta2.46
Next Earnings
Nov 10, 2025EPS Estimate
-2.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.23
Shares Outstanding5,894,024
10 Day Avg. Volume188,498
30 Day Avg. Volume88,270
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.85
Enterprise Value/Revenue16.16
Enterprise Value/Gross Profit-138.41
Enterprise Value/Ebitda-0.57
Forecast
1Y Price Target
$10.00Price Target Upside64.47% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
Bulls Say, Bears Say
Bulls Say
Leadership ChangeA new CEO with over 20 years of leadership in the healthcare and financial industry has been appointed, bringing valuable experience to lead the company through its current development and clinical programs.
Strategic VisionThe strategic vision focuses on completing a fully integrated, production-equivalent system and initiating full system verification and validation, which is considered the best use of company resources.
Bears Say
Cash Flow ManagementRBOT's capital position remains its biggest challenge as RBOT exited 2Q25 with ~$24.0M in cash and continues to expect ~$50M in cash burn for FY25 forcing RBOT to make some tough decisions.
Clinical Testing TimelineThe shift in strategy means delaying the treatment of the first clinical patients, prioritizing finalizing a production-equivalent system instead.
Product Development DelaysThe company will hold off on its clinical trial initiation in order to further develop its system to be 'product ready', indicating a pause until further notice.
Vicarious Surgical News
RBOT FAQ
What was Vicarious Surgical Inc.’s price range in the past 12 months?
Vicarious Surgical Inc. lowest stock price was $5.00 and its highest was $19.00 in the past 12 months.
What is Vicarious Surgical Inc.’s market cap?
Vicarious Surgical Inc.’s market cap is $39.81M.
When is Vicarious Surgical Inc.’s upcoming earnings report date?
Vicarious Surgical Inc.’s upcoming earnings report date is Nov 10, 2025 which is in 23 days.
How were Vicarious Surgical Inc.’s earnings last quarter?
Vicarious Surgical Inc. released its earnings results on Aug 12, 2025. The company reported -$2.23 earnings per share for the quarter, beating the consensus estimate of -$2.497 by $0.267.
Is Vicarious Surgical Inc. overvalued?
According to Wall Street analysts Vicarious Surgical Inc.’s price is currently Undervalued.
Does Vicarious Surgical Inc. pay dividends?
Vicarious Surgical Inc. does not currently pay dividends.
What is Vicarious Surgical Inc.’s EPS estimate?
Vicarious Surgical Inc.’s EPS estimate is -2.33.
How many shares outstanding does Vicarious Surgical Inc. have?
Vicarious Surgical Inc. has 5,894,024 shares outstanding.
What happened to Vicarious Surgical Inc.’s price movement after its last earnings report?
Vicarious Surgical Inc. reported an EPS of -$2.23 in its last earnings report, beating expectations of -$2.497. Following the earnings report the stock price went down -24.348%.
Which hedge fund is a major shareholder of Vicarious Surgical Inc.?
Currently, no hedge funds are holding shares in RBOT
Vicarious Surgical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (64.47% Upside)
$10.00 (64.47% Upside)
Insider Transactions
Sold Shares
Worth $31.5K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.3%
Last 30 Days ▲ 18.9%
Last 30 Days ▲ 18.9%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-16.76%
12-Months-Change
Fundamentals
Return on Equity
-125.63%
Trailing 12-Months
Asset Growth
-56.20%
Trailing 12-Months
Company Description
Vicarious Surgical Inc.
Vicarious Surgical (RBOT) is a medical technology company that specializes in developing innovative robotic systems designed to enhance minimally invasive surgery. The company's core product is its advanced robotic platform, which integrates proprietary human-like surgical robots with 3D visualization and AI-driven insights to improve surgical precision and outcomes. Vicarious Surgical aims to revolutionize the field of surgery by providing surgeons with enhanced capabilities, improved ergonomics, and reduced procedure times.
RBOT Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a company undergoing significant leadership transition and strategic reassessment. While there are positives in the form of reduced operating expenses and net loss, major challenges remain, particularly around delays in clinical trials and resource constraints. The uncertainty in achieving future milestones further complicates the outlook.View all RBOT earnings summariesRBOT Stock 12 Month Forecast
Average Price Target
$10.00
▲(64.47% Upside)
Technical Analysis
LivaNova
―
Xtant Medical Holdings
―
Inspire Medical Systems
―
Outset Medical
―
PROCEPT BioRobotics
―
Ownership Overview
13.07% Insiders
3.49% Mutual Funds
<0.01% Other Institutional Investors
80.75% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---